NCT02191202View on ClinicalTrials.gov

Impact of Switching to NNRTI-based Therapy on the Quality of Life of HIV-infected Patients With Virological Suppression

CompletedOBSERVATIONAL
Enrollment

283

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

February 28, 2006

Conditions
HIV Infections
Interventions
DRUG

Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY